Benefits of adjuvant chemo for soft tissue sarcoma patients

3 Views
administrator
administrator
07/18/23

Dr Gronchi speaks with ecancertv at ESMO 2016 about the responses of patients with advanced soft tissue sarcoma to adjuvant epirubicin plus ifosfamide compared to those receiving a tailored chemo regimen based on histology subgrouping

He reports significantly improved relapse-free survival and overall survival for patients receiving adjuvant chemo, thought notes the trial is a technical failure due to being powered for the histology-tailored sub types which did not show any benefit.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next